Michelle J Boyle
The goal of Dr Boyle’s research is to understand mechanisms of protective immunity targeting malaria parasites in humans. This includes the role of complement in mediating antibody function and parasite killing. Dr Boyle’s research has shown that the large proportion of acquired human antibodies require complement to function. Antibodies interact with C1q to block invasion and drive Membrane Attack Complex (MAC) formation to lyse malaria parasites.
Dr Boyle completed her PhD at the University of Melbourne and Burnet Institute in 2012. She conducted post-doctoral studies at the University of California, San Francisco, and since returning to Australia has been based at the Menzies School of Health Research, Darwin, where she holds an Honorary Fellow appointment. She was recently appointed as a QIMR-Berghofer, EMBL Australian Group Leader, and she will take up this position in late 2018.
Abstracts this author is presenting: